Cargando…
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
Artemisinin and its derivatives (collectively referred to as ARTs) rapidly reduce the parasite burden in Plasmodium falciparum infections, and antimalarial control is highly dependent on ART combination therapies (ACTs). Decreased sensitivity to ARTs is emerging, making it critically important to un...
Autores principales: | Bridgford, Jessica L., Xie, Stanley C., Cobbold, Simon A., Pasaje, Charisse Flerida A., Herrmann, Susann, Yang, Tuo, Gillett, David L., Dick, Lawrence R., Ralph, Stuart A., Dogovski, Con, Spillman, Natalie J., Tilley, Leann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143634/ https://www.ncbi.nlm.nih.gov/pubmed/30228310 http://dx.doi.org/10.1038/s41467-018-06221-1 |
Ejemplares similares
-
Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins
por: Xie, Stanley C., et al.
Publicado: (2016) -
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
por: Dogovski, Con, et al.
Publicado: (2015) -
A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum
por: Cao, Pengxing, et al.
Publicado: (2017) -
Target Validation and Identification of Novel Boronate
Inhibitors of the Plasmodium falciparum Proteasome
por: Xie, Stanley C., et al.
Publicado: (2018) -
Plasmodium falciparum resistance to artemisinin-based combination therapies
por: Ward, Kurt E, et al.
Publicado: (2022)